Roth Capital Starts Intec Pharma Ltd. (NTEC) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Maxim Group Starts Intec Pharma Ltd. (NTEC) at Buy
September 15, 2015 5:00 PM EDTMaxim Group initiates coverage on Intec Pharma Ltd. (NASDAQ: NTEC) with a Buy rating and a price target of $9.00.
Analyt Jason Kolbert commented, "In August 2015, Intec Pharmaceuticals completed its IPO, raising approximately $30M. This is enough capital for its Phase III single (505B2... More
